Ziyang Liu

Ziyang Liu

Auto-generated profile, based on publicly available information

Ziyang Liu

Department of Immunology, Guangzhou Institute of Paediatrics, Guangzhou Women and Children’s Medical Centre, and State Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2020 in Science
Verified
Journal Article
Closed access
RLRuoyan Li
Ruoyan Li
YDYiqin Du
Yiqin Du
ZCZhanghua Chen
Zhanghua Chen
DXDeshu Xu
Deshu Xu
Tianxin LinTianxin Lin
Tianxin Lin
FBFan Bai
Fan Bai
Genetic profiles of the bladder: Depending on the environment of the individual, the human bladder can be exposed to carcinogens as they are flushed through the body. Lawson et al. and Li et al. examined the genetic composition of laser-dissected microbiopsies from normal and cancer cells collected from the urothelium, a specialized epithelium lining the lower urinary tract (see the Perspective by Rozen). These complementary studies identified the mutational landscape of bladder urothelium through various sequencing strategies and identified high mutational heterogeneity within and between individuals and tumors. Both studies identified mutational profiles related to specific carcinogens such as aristolochic acid and the molecules found in tobacco. These studies present a comprehensive description of the diverse mutational landscape of the human bladder in health and disease, unraveling positive selection for cancer-causing mutations, a diversity of mutational processes, and large differences across individuals. Science , this issue p. 75 , p. 82 ; see also p. 34

3 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
XLXiangjun Liu
Xiangjun Liu
SJShanzhao Jin
Shanzhao Jin
SHSimeng Hu
Simeng Hu
RLRuoyan Li
Ruoyan Li
HPHaihao Pan
Haihao Pan
YWYang Wang
Yang Wang
Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of non-Hodgkin lymphoma distinguished by the presence of clonal malignant T cells. The heterogeneity of malignant T cells and the complex tumor microenvironment remain poorly characterized. With single-cell RNA analysis and bulk whole-exome sequencing on 19 skin lesions from 15 CTCL patients, we decipher the intra-tumor and inter-lesion diversity of CTCL patients and propose a multi-step tumor evolution model. We further establish a subtyping scheme based on the molecular features of malignant T cells and their pro-tumorigenic microenvironments: the TCyEM group, demonstrating a cytotoxic effector memory T cell phenotype, shows more M2 macrophages infiltration, while the TCM group, featured by a central memory T cell phenotype and adverse patient outcome, is infiltrated by highly exhausted CD8+ reactive T cells, B cells and Tregs with suppressive activities. Our results establish a solid basis for understanding the nature of CTCL and pave the way for future precision medicine for CTCL patients.

7 November 2019 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
YLYanmeng Li
Yanmeng Li
XLXiao Li
Xiao Li
HLHao Li
Hao Li
YZYifan Zhao
Yifan Zhao
ZLZiyang Liu
Ziyang Liu
JWJun Wang
Jun Wang
Background: Lung adenocarcinomas (LUADs) that display radiologically as subsolid nodules (SSNs) exhibit more indolent biological behaviour than solid LUADs. SSNs, commonly encompassing pre-invasive and invasive yet early-stage adenocarcinomas, can be categorised as pure ground-glass nodules and part-solid nodules. The genomic characteristics of SSNs remain poorly understood.Methods: We subjected 154 SSN samples from 120 treatment-naïve Chinese patients to whole-exome sequencing. Clinical parameters and radiological features of these SSNs were collected. The genomic landscape of SSNs and differences from that of advanced-stage LUADs were defined. In addition, we investigated the intratumour heterogeneity and clonal relationship of multifocal SSNs and conducted radiogenomic analysis to link imaging and molecular characteristics of SSNs. Fisher's exact and Wilcoxon rank sum tests were used in the statistical analysis.Results: The median somatic mutation rate across the SSN cohort was 1.12 mutations per Mb. Mutations inEGFRwere the most prominent and significant variation, followed by those inRBM10,TP53,STK11andKRAS. The differences between SSNs and advanced-stage LUADs at a genomic level were unravelled. Branched evolution and remarkable genomic heterogeneity were demonstrated in SSNs. Although multicentric origin was predominant, we also detected early metastatic events among multifocal SSNs. Using radiogenomic analysis, we found that higher ratios of solid components in SSNs were accompanied by significantly higher mutation frequencies inEGFR,TP53,RBM10andARID1B, suggesting that these genes play roles in the progression of LUADs.Conclusions: Our study provides the first comprehensive description of the mutational landscape and radiogenomic mapping of SSNs.

3 June 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
MAMahmoud Al-Azab
Mahmoud Al-Azab
EIElina Idiiatullina
Elina Idiiatullina
ZLZiyang Liu
Ziyang Liu
MLMeng Lin
Meng Lin
KHKatja Hrovat-Schaale
Katja Hrovat-Schaale
SMSeth L. Masters
Seth L. Masters
Rare genetic variants in toll-like receptor 7 (TLR7) are known to cause lupus in humans and mice. UNC93B1 is a transmembrane protein that regulates TLR7 localization into endosomes. In the present study, we identify two new variants in UNC93B1 (T314A, located proximally to the TLR7 transmembrane domain, and V117L) in a cohort of east Asian patients with childhood-onset systemic lupus erythematosus. The V117L variant was associated with increased expression of type I interferons and NF-κB-dependent cytokines in patient plasma and immortalized B cells. THP-1 cells expressing the variant UNC93B1 alleles exhibited exaggerated responses to stimulation of TLR7/-8, but not TLR3 or TLR9, which could be inhibited by targeting the downstream signaling molecules, IRAK1/-4. Heterozygous mice expressing the orthologous Unc93b1V117L variant developed a spontaneous lupus-like disease that was more severe in homozygotes and again hyperresponsive to TLR7 stimulation. Together, this work formally identifies genetic variants in UNC93B1 that can predispose to childhood-onset systemic lupus erythematosus.

30 July 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
ZLZiyang Liu
Ziyang Liu
AWAnqiang Wang
Anqiang Wang
YPYingying Pu
Yingying Pu
ZLZhongwu Li
Zhongwu Li
RXRuidong Xue
Ruidong Xue
JJJiafu Ji
Jiafu Ji

6 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
EIElina Idiiatullina
Elina Idiiatullina
MAMahmoud Al-Azab
Mahmoud Al-Azab
MLMeng Lin
Meng Lin
KHKatja Hrovat-Schaale
Katja Hrovat-Schaale
ZLZiyang Liu
Ziyang Liu
SMSeth L. Masters
Seth L. Masters
Mitochondrial RNA (mtRNA) in the cytosol can trigger the innate immune sensor MDA5, and autoinflammatory disease due to type I IFN. Here, we show that a dominant negative mutation in the gene encoding the mitochondrial exonuclease REXO2 may cause interferonopathy by triggering the MDA5 pathway. A patient characterized by this heterozygous de novo mutation (p.T132A) presented with persistent skin rash featuring hyperkeratosis, parakeratosis and acanthosis, with infiltration of lymphocytes and eosinophils around small blood vessels. In addition, circulating IgE levels and inflammatory cytokines, including IFNα, are found consistently elevated. Transcriptional analysis highlights a type I IFN gene signature in PBMC. Mechanistically, REXO2 (T132A) lacks the ability to cleave RNA and inhibits the activity of wild-type REXO2. This leads to an accumulation of mitochondrial dsRNA in the cytosol, which is recognized by MDA5, leading to the associated type I IFN gene signature. These results demonstrate that in the absence of appropriate regulation by REXO2, aberrant cellular nucleic acids may accumulate and continuously trigger innate sensors, resulting in an inborn error of immunity.